Generalized skin eruption due to drugs and medicaments taken internally
ICD-10 L27.0 is a billable code used to indicate a diagnosis of generalized skin eruption due to drugs and medicaments taken internally.
Generalized skin eruption due to drugs and medicaments taken internally, classified under ICD-10 code L27.0, refers to a widespread rash or skin reaction resulting from systemic exposure to pharmacological agents. Clinically, patients may present with various types of eruptions, including maculopapular rashes, urticaria, or even more severe reactions like Stevens-Johnson syndrome. The skin, being the largest organ, can exhibit diverse responses to drugs, often involving the epidermis and dermis layers. Disease progression can vary; some patients may experience immediate reactions, while others may have delayed hypersensitivity responses. Diagnostic considerations include a thorough patient history to identify potential offending agents, physical examination of the skin lesions, and, if necessary, skin tests or biopsies to rule out other dermatological conditions. It is crucial to differentiate drug eruptions from other skin disorders, as management involves discontinuation of the offending medication and symptomatic treatment.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L27.0 encompasses generalized skin eruptions such as drug-induced urticaria, maculopapular rashes, and more severe reactions like drug-induced hypersensitivity syndrome. It is essential to establish a clear link between the eruption and the medication taken.
L27.0 should be used when the skin eruption is widespread and directly linked to systemic medication use. If the eruption is localized or due to a specific allergen, other codes like L27.1 may be more appropriate.
Documentation should include a comprehensive drug history, details of the onset and progression of the skin eruption, physical examination findings, and any diagnostic tests performed to rule out other conditions.
